Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry

Published:2022-08 Issue: Volume:25 Page:53-60
ISSN:2667-145X
Container-title:Journal of Mass Spectrometry and Advances in the Clinical Lab
language:en
Short-container-title:Journal of Mass Spectrometry and Advances in the Clinical Lab

Author:

Hallin Erik I.,Trætteberg Serkland Trond,Myhr Kjell-Morten,Torkildsen Øivind,Skrede Silje

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Medical Laboratory Technology,Spectroscopy,Microbiology

Reference36 articles.

1. Diagnosis and Treatment of Multiple Sclerosis: A Review;McGinley;JAMA.,2021

2. Multiple sclerosis;Thompson;Lancet.,2018

3. Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N Engl J Med. 2017 Jan 19;376(3):221-234. 10.1056/NEJMoa1601277. Epub 2016 Dec 21.

4. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis;Montalban;N Engl J Med.,2017

5. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination;Storch;Ann Neurol.,1998

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospitalisations and humoral COVID-19 vaccine response in vaccinated rituximab-treated multiple sclerosis patients;Multiple Sclerosis and Related Disorders;2024-09

2. High-throughput, low-cost quantification of 11 therapeutic antibodies using caprylic acid precipitation and LC-MS/MS;Analytica Chimica Acta;2024-07

3. Integration of protein L-immobilized epoxy magnetic bead capture with LC-MS/MS for therapeutic monoclonal antibody quantification in serum;Analytical Methods;2024

4. A Liquid Chromatography - Tandem Mass Spectrometry Method for Determination of Ocrelizumab in Serum of Patients with Multiple Sclerosis;2024

5. Ocrelizumab and ofatumumab, but not rituximab, trigger complement induction in vitro;International Immunopharmacology;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3